Medicinal Cannabis Player Cann Group (ASX:CAN) Secures Loan Facility with NAB

  • November 23, 2020 12:24 PM AEDT
  • Kunal Sawhney
    Kunal Sawhney
    CEO Kunal Sawhney
    2781 Posts

    Kunal Sawhney is founder & CEO at Kalkine and is a richly experienced and accomplished financial professional with a wealth of knowledge in the Australian Equities Market. Kunal obtained a Master of Business Administration degree from University of T...

Medicinal Cannabis Player Cann Group (ASX:CAN) Secures Loan Facility with NAB

Summary

  • Cann Group has disclosed that it has secured credit approval for a debt facility worth A$50 million debt from National Australia Bank (NAB).
  • Debt funding with NAB clears the Company’s path to restart construction on the Mildura production facility.
  • The Company stated that securing the support of a tier-one bank substantiates its strategic growth plans.

ASX-listed medical cannabis company Cann Group Limited (ASX:CAN) has announced today that it has secured a A$50 million secured debt facility with National Australia Bank Limited (ASX:NAB).

Following the significant announcement, CAN’s share price surged with the stock trading 14.516% higher at A$0.355 ( at AEDT 12:24 PM). The market capitalisation of Cann Group stood at A$83.67 million.

About Cann Group

Medical cannabis player Cann Group Limited is engaged in building a world-class business focused on breeding, cultivating, manufacturing, and supplying medicinal cannabis. The Company develops cannabis products for sale and use within Australia as well as for approved overseas export markets.

Cann Group is commercialising several imported as well as locally sourced and produced medicinal cannabis formulations.

Cann Group Secures A$50 million Debt Facility Approval

On 23 November 2020, Cann Group revealed that it obtained credit approval for a A$50 million secured debt facility from National Australia Bank Limited. The Company anticipates completing execution of documentation with the Bank within the next month.

The loan is a construction facility which will be utilised for completion of the first stage of its state-of-the-art medicinal cannabis production site near Mildura. The loan is being provided via the agribusiness division of NAB and represents a robust endorsement of strategic growth plans of Can Group.

Mildura production facility expected to Start in February 2021

The Company notified that this debt funding clears the path to restart construction on its Mildura production facility. The work at Mildura facility is anticipated to be underway in February 2021.

The first-stage of Mildura has an estimated build time of nine months, with first product anticipated to be processed and released by March 2022.

Cann Group also notified that the first stage of the project would offer the annual capacity to deliver 12.5 kgs of dry flower equivalent.

Moreover, the total estimated cost for completing the initial stage is almost A$112 million, with Cann Group having already expended ~A$53 million on-site works and the facility superstructure. The balance of projected costs of about A$59 million will be funded through the current cash reserves and new bank loan facility.

Cann Group CEO Peter Crock stated that specialist overseas contractors had been cleared to arrive as part of the workforce remobilisation program in Australia in the new year.

Mr Crock also added-

ALSO READ: Has Cannabis Come of age to tackle COVID-19?

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK